Phialogics

Developer of cell therapies for the treatment of auto-immune diseases

placeFrankfurt Am Main, Hesse, Germany calendar_todayFounded 2021 groups5 employees language phialogics.com

Registered entities

Social engagement

Social engagement: 959 social following, 8 posts in the last 12 months — top 10% of its industry.

Investor mix

3 investors on record; lead investors include HTGF.

Investor typeCountShare
Venture capital133%
Accelerator & incubator267%

Recent activity

13 Nov 2025
Recognition
7 Nov 2025
Recognition
25 Sep 2025
Event
Festival of Biologics
Coming soon